Author details

Full Name

Eric Lau

Affiliation

Moffitt Cancer Center

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

Trey Ideker (CM4AI)

PMID	Paper Title	Journal Title	Published Year
34070332	Fucosylated Proteome Profiling Identifies a Fucosylated, Non-Ribosomal, Stress-Responsive Species of Ribosomal Protein S3.	Cells	2021
30987999	HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy.	Cancer Res	2019
31450600	The Diverse Contributions of Fucose Linkages in Cancer.	Cancers (Basel)	2019
29924834	The fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation in melanoma cells.	PLoS One	2018
29061795	Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.	Anticancer Res	2017
28212892	ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease.	Pharmacol Res	2017
27210757	A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.	Cell Rep	2016
26638885	Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer.	Curr Cancer Drug Targets	2016
25728676	Transcriptional repression of IFNÎ²1 by ATF2 confers melanoma resistance to therapy.	Oncogene	2015
26603897	SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex.	Cancer Res	2015
26645581	The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation.	Sci Signal	2015
25963442	ATF2 alters melanocyte response and macrophage recruitment in UV-irradiated neonatal mouse skin.	Pigment Cell Melanoma Res	2015
25712345	PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets.	Cancer Res	2015
25759021	Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies.	Cancer Cell	2015
24809345	Fine tuning of the UPR by the ubiquitin ligases Siah1/2.	PLoS Genet	2014
23035722	Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.	Pigment Cell Melanoma Res	2013
23902736	Small molecule-induced mitochondrial disruption directs prostate cancer inhibition via UPR signaling.	Oncotarget	2013
23589174	Inhibition of melanoma growth by small molecules that promote the mitochondrial localization of ATF2.	Clin Cancer Res	2013
22304920	PKCÎµ promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria.	Cell	2012
22685333	ATF2 - at the crossroad of nuclear and cytosolic functions.	J Cell Sci	2012
21540889	RAF-isotype switching: from B to C through PDE.	Nat Struct Mol Biol	2011
20029425	Emerging roles of ATF2 and the dynamic AP1 network in cancer.	Nat Rev Cancer	2010
21203491	A role for ATF2 in regulating MITF and melanoma development.	PLoS Genet	2010
19587119	Divergent S phase checkpoint activation arising from prereplicative complex deficiency controls cell survival.	Mol Biol Cell	2009
19111665	The role of Dbf4/Drf1-dependent kinase Cdc7 in DNA-damage checkpoint control.	Mol Cell	2008
17690155	The role of pre-replicative complex (pre-RC) components in oncogenesis.	FASEB J	2007
16603632	Spatiotemporal control of spindle midzone formation by PRC1 in human cells.	Proc Natl Acad Sci U S A	2006
16439999	The functional role of Cdc6 in S-G2/M in mammalian cells.	EMBO Rep	2006
16880740	Is there a pre-RC checkpoint that cancer cells lack?	Cell Cycle	2006

1 - 29 of 29

Alexandre Rosa Campos

Sanford Burnham Prebys Medical Discovery Institute

Career Start Year 2015

Number of shared co-authors 1

Min Gao

College of Horticulture, China Agricultural University

Career Start Year 2012

Number of shared co-authors 1

Thibault Houles

Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal

Career Start Year 2011

Number of shared co-authors 0

Aleksandra M Michalowski

Center for Cancer Research, National Cancer Institute

Career Start Year 2010

Number of shared co-authors 0

Yi-Hung Ou

The First Affiliated Hospital of Guangdong Pharmaceutical University

Career Start Year 2005

Number of shared co-authors 1

Maggie Cam

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2005

Number of shared co-authors 0

Genevi??ve Lavoie

Institute for Research in Immunology and Cancer (IRIC)

Career Start Year 2004

Number of shared co-authors 1

Silvano Piazza

International Centre for Genetic Engineering and Biotechnology

Career Start Year 2004

Number of shared co-authors 1

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 6

Barak Rotblat

Ben-Gurion University of the Negev

Career Start Year 2002

Number of shared co-authors 0

Luigi Nezi

Istituto Europeo di Oncologia IRCCS

Career Start Year 2002

Number of shared co-authors 2

Tarek Abbas

University of Virginia

Career Start Year 2001

Number of shared co-authors 0

Aaron Aslanian

Salk Institute for Biological Studies

Career Start Year 1998

Number of shared co-authors 1

Jianjun Shen

The University of Texas MD Anderson Cancer Center

Career Start Year 1998

Number of shared co-authors 4

Jun Yao

The University of Texas MD Anderson Cancer Center

Career Start Year 1997

Number of shared co-authors 1

Yaoqi Alan Wang

The University of Texas MD Anderson Cancer Center

Career Start Year 1997

Number of shared co-authors 0

Shiaw-Yih Lin

The University of Texas MD Anderson Cancer Center

Career Start Year 1996

Number of shared co-authors 1

John Alan Diehl

Case Western Reserve University School of Medicine

Career Start Year 1993

Number of shared co-authors 3

Christoph Reinhard

Lilly Research Laboratories

Career Start Year 1992

Number of shared co-authors 1

Peter D Adams

Sanford Burnham Prebys Medical Discovery Institute

Career Start Year 1991

Number of shared co-authors 3

Qimin Zhan

Peking University Cancer Hospital

Career Start Year 1989

Number of shared co-authors 0

Wei Zhang

The University of Texas MD Anderson Cancer Center

Career Start Year 1988

Number of shared co-authors 1

Daniel S Peeper

Netherlands Cancer Institute

Career Start Year 1987

Number of shared co-authors 3

Rakesh Kumar

Rutgers New Jersey Medical School

Career Start Year 1987

Number of shared co-authors 4

Rosalie C Sears

Oregon Health and Science University

Career Start Year 1987

Number of shared co-authors 5

Lori S Hart

Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research

Career Start Year 1987

Number of shared co-authors 1

William C Hahn

Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute

Career Start Year 1987

Number of shared co-authors 6

Ashok R Venkitaraman

University of Cambridge, Hutchison Research Centre

Career Start Year 1982

Number of shared co-authors 0

Stephen J Elledge

Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School

Career Start Year 1982

Number of shared co-authors 1

Francisca Vazquez

Broad Institute of MIT and Harvard

Career Start Year 1979

Number of shared co-authors 1

row(s) 1 - 30 of 30

Ze'ev Ronai

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 16

Yongmei Feng

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 7

Marcus Bosenberg

Yale School of Medicine

Co-authored papers 6

Marzia Scortegagna

NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 5

Hyungsoo Kim

Sungkyunkwan University

Co-authored papers 4

Giuseppina Claps

Institut National de la Sante et de la Recherche Medicale (INSERM) U

Co-authored papers 4

Harriet M Kluger

Yale School of Medicine

Co-authored papers 3

Stan Krajewski

Cellstan-Immunoquant Inc.

Co-authored papers 3

Reinhard Dummer

University Hospital Zurich

Co-authored papers 2

Lynda Chin

Co-authored papers 2

Michael A Davies

The University of Texas MD Anderson Cancer Center

Co-authored papers 2

Trey Ideker (CM4AI)

University of California San Diego

Co-authored papers 2

Christian A Hassig

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 2

John M Koomen

Co-authored papers 2

Anthony B Pinkerton

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 2

Brian James

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 2

David L Rimm

Yale University School of Medicine

Co-authored papers 2

Tal Varsano

Sanford-Burnham Medical Research Institute

Co-authored papers 2

Cindy Sander

UPMC Hillman Cancer Center

Co-authored papers 1

Carl F Ware

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 1

Rohith Srivas

Amgen Inc.

Co-authored papers 1

Rene Gonzalez

University of Colorado Anschutz Medical Campus

Co-authored papers 1

Wolfgang Breitwieser

Cancer Research United Kingdom Manchester Institute, University of Manchester

Co-authored papers 1

Immo E Scheffler

University of California

Co-authored papers 1

Misa A Shaw

West Virginia University School of Medicine

Co-authored papers 1

John M Kirkwood

UPMC Hillman Cancer Center

Co-authored papers 1

Ivan Topisirovic

McGill University

Co-authored papers 1

Stephen Soonthornvacharin

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 1

Phil F Cheng

University Hospital of Zurich

Co-authored papers 1

David D L Bowtell

Peter MacCallum Cancer Centre

Co-authored papers 1

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators